ondansetron has been researched along with Bone Cancer in 11 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient completed the remainder of the radiation treatment with no further emesis and minimal nausea, representing the first documented success of granisetron and aprepitant for RINV after failure on ondansetron." | 7.81 | Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report. ( Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L, 2015) |
| "The patient completed the remainder of the radiation treatment with no further emesis and minimal nausea, representing the first documented success of granisetron and aprepitant for RINV after failure on ondansetron." | 3.81 | Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report. ( Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L, 2015) |
| "The efficacy and safety of ondansetron has led to the widespread use of this medication in the treatment of nausea and vomiting caused by cancer chemotherapy and radiation therapy." | 3.69 | Anaphylactoid reactions associated with ondansetron. ( Kossey, JL; Kwok, KK, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rowbottom, L | 1 |
| Pasetka, M | 2 |
| McDonald, R | 1 |
| Hunyh, L | 1 |
| Raman, S | 1 |
| DeAngelis, C | 3 |
| Chow, E | 3 |
| Chiu, N | 1 |
| Chiu, L | 1 |
| Popovic, M | 1 |
| Lutz, S | 1 |
| Zhang, N | 1 |
| Marta, GN | 1 |
| Mendez, LC | 1 |
| Lechner, B | 1 |
| Pulenzas, N | 1 |
| Milakovic, M | 1 |
| Chow, R | 1 |
| Pillai, AK | 1 |
| Sharma, KK | 1 |
| Gupta, YK | 1 |
| Bakhshi, S | 1 |
| Dennis, K | 1 |
| Nguyen, J | 1 |
| Presutti, R | 1 |
| Tsao, M | 1 |
| Danjoux, C | 1 |
| Barnes, E | 1 |
| Sahgal, A | 1 |
| Holden, L | 1 |
| Jon, F | 1 |
| Wong, S | 1 |
| Takenaka, M | 1 |
| Okamoto, Y | 1 |
| Ikeda, K | 1 |
| Hashimoto, R | 1 |
| Ueda, T | 1 |
| Kurokawa, N | 1 |
| Takagi, T | 1 |
| Uejima, E | 1 |
| Gallegos-Castorena, S | 1 |
| Martínez-Avalos, A | 1 |
| Mohar-Betancourt, A | 1 |
| Guerrero-Avendaño, G | 1 |
| Zapata-Tarrés, M | 1 |
| Medina-Sansón, A | 1 |
| Cole, RM | 1 |
| Robinson, F | 1 |
| Harvey, L | 1 |
| Trethowan, K | 1 |
| Murdoch, V | 1 |
| Kossey, JL | 1 |
| Kwok, KK | 1 |
| Forni, C | 1 |
| Ferrari, S | 1 |
| Loro, L | 1 |
| Mazzei, T | 1 |
| Beghelli, C | 1 |
| Biolchini, A | 1 |
| Simoni, P | 1 |
| Tremosini, M | 1 |
| Strazzari, S | 1 |
| Puggioli, C | 1 |
| Bacci, G | 1 |
| Postovsky, S | 1 |
| Elhasid, R | 1 |
| Ben-Barak, A | 1 |
| Levin, K | 1 |
| Ben Arush, MW | 1 |
| Nicholson, S | 1 |
| Evans, C | 1 |
| Mansi, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Study to Evaluate the Anti-Emetic Effect of Ginger Powder Vs Placebo as an Add-on Therapy in Children and Adolescents Receiving Chemotherapy : A Randomized Controlled Trial[NCT00940368] | Phase 3 | 60 participants (Anticipated) | Interventional | 2009-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ondansetron and Bone Cancer
| Article | Year |
|---|---|
Latest advances in the management of radiation-induced pain flare, nausea and vomiting.
Topics: Antiemetics; Bone Neoplasms; Dexamethasone; Humans; Methylprednisolone; Musculoskeletal Pain; Nausea | 2016 |
3 trials available for ondansetron and Bone Cancer
| Article | Year |
|---|---|
Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisp | 2011 |
Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
Topics: Adolescent; Amifostine; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2007 |
Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions.
Topics: Acute Disease; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone | 2000 |
7 other studies available for ondansetron and Bone Cancer
| Article | Year |
|---|---|
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; | 2015 |
Prophylaxis of radiotherapy-induced nausea and vomiting in the palliative treatment of bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Bone Neoplasms; Female; Humans; Male; Middle Aged; Naus | 2012 |
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles | 2007 |
Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer.
Topics: Analgesics; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Haloperidol; Humans | 1994 |
Anaphylactoid reactions associated with ondansetron.
Topics: Adult; Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cis | 1994 |
Allergic reaction to high-dose methotrexate.
Topics: Adolescent; Anti-Anxiety Agents; Antimetabolites, Antineoplastic; Antipruritics; Bone Neoplasms; Dip | 2000 |
Ondansetron in intractable nausea and vomiting.
Topics: Adult; Antiemetics; Bone Neoplasms; Breast Neoplasms; Female; Humans; Imidazoles; Nausea; Ondansetro | 1992 |